Lebrikizumab in the personalized management of asthma

Lebrikizumab in the personalized management of asthma

Reviews the potential role of interleukin (IL)-13 in the pathogenesis of asthma, the efficacy and safety of lebrikizumab - a humanised monoclonal antibody that binds to IL-13 - in humans, and progress in patient selection for lebrikizumab therapy. Source: National Library of New Zealand Te Puna Mata...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biologics 2012-01, Vol.6 (default), p.329-335
Hauptverfasser: Thomson, Neil C, Patel, Manish, Smith, Andrew D
Format: Artikel
Sprache:eng
Schlagworte:
Asthma
Corticosteroids
Development and progression
Dosage and administration
Drug therapy
Helper cells
Interleukin-13
Molecular aspects
Monoclonal antibodies
Pathophysiology
Review
Therapeutic use
Treatment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Reviews the potential role of interleukin (IL)-13 in the pathogenesis of asthma, the efficacy and safety of lebrikizumab - a humanised monoclonal antibody that binds to IL-13 - in humans, and progress in patient selection for lebrikizumab therapy. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
ISSN:1177-5475
1177-5491
1177-5491
1177-5475
DOI:10.2147/BTT.S28666